Physician

Alaleh Mazhari, D.O.

According to 2025 Medicare claims, Alaleh Mazhari, D.O. (NPI: 1326299611) practices endocrinology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is LOYOLA UNIVERSITY MEDICAL CENTER (NPI: 1336159961; TIN: 364015560) and primary practice location at 60153-3328. Mazhari is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

Mazhari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 624 HCPCS/CPT codes, and received $44,939 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,068 prescription claims across 604 beneficiaries totaling $1,551,710 in drug costs, led by Ozempic (Semaglutide). DME data shows 537 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $643,858 to $1,551,710. For DME billing, reported payments moved sharply higher in recent years, from $985 to $166,052.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	445	841	$53,470
2016	511	962	$61,572
2017	515	943	$59,273
2018	547	1,005	$60,906
2019	568	1,019	$65,240
2020	487	830	$51,267
2021	500	869	$68,716
2022	467	812	$61,059
2023	447	698	$51,243
2024	436	624	$44,939

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	313	2,330	$643,858
2016	358	2,943	$860,374
2017	400	3,334	$1,138,681
2018	441	3,554	$1,452,528
2019	478	3,557	$1,472,904
2020	504	3,653	$1,520,619
2021	551	3,959	$1,836,163
2022	537	3,945	$2,053,124
2023	561	3,901	$2,257,723
2024	604	4,068	$1,551,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	169	373	$8,118
2016	182	450	$9,977
2017	190	449	$9,069
2018	214	544	$19,703
2019	181	503	$29,601
2020	179	565	$55,439
2021	187	609	$66,289
2022	188	866	$129,003
2023	183	903	$152,477
2024	142	537	$166,587

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	42	46	$111
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	36	36	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	343	432	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	19	52	$57
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	18	26	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	229	11,984	$365,775
Mounjaro	Tirzepatide	219	7,004	$237,468
Jardiance	Empagliflozin	136	9,076	$174,658
Tradjenta	Linagliptin	100	7,396	$122,254
Trulicity	Dulaglutide	64	2,548	$80,130

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	83	354	$151,872
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	27	$5,954
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	19	$5,320
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	21	$1,748
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	39	81	$1,640

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alaleh Mazhari, D.O.?

Tedicare shows public-source Medicare data for Alaleh Mazhari, D.O. (NPI 1326299611), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alaleh Mazhari, D.O. have ACO affiliation data?

Alaleh Mazhari, D.O. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to Alaleh Mazhari, D.O.?

Alaleh Mazhari, D.O. is linked to LOYOLA UNIVERSITY MEDICAL CENTER (billing NPI 1336159961) in the available physician profile data.

Does Alaleh Mazhari, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.